Progressive chronic chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives

American Journal of Tropical Medicine and Hygiene

Volumn 63, Issue 3-4, 2000, Pages 111-118

  Lauria Pires, Liana ^a   Braga, Maria S ^a   Vexenat, Ana C ^a   Nitz, Nadjar ^a   Simões Barbosa, Augusto ^a   Tinoco, Douglas L ^a   Teixeira, Antonio R L ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; BENZNIDAZOLE; CELL NUCLEUS DNA; NIFURTIMOX; NITRO DERIVATIVE; PROTOZOON ANTIBODY;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CHAGAS DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DISEASE COURSE; DRUG EFFICACY; ELECTROCARDIOGRAPHY; ERADICATION THERAPY; FOLLOW UP; HEADACHE; HUMAN; MENTAL DISEASE; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; SEIZURE; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING; TRYPANOSOMA CRUZI; VISUAL DISORDER;

EID: 0034443066     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2000.63.111     Document Type: Article

References (46)

1. Campos de Carvalho AC, Masuda MO, Tanowitz HB, Wittner MW, Goldenberg C, Spray DC, 1994. Conduction defects and arrhythmias in Chagas disease. Possible role of gap junctions and humoral mechanisms. J Cardiov Electrophys 5: 686-698.
2. Maguirre JH, Hoff R, Sherlock I, Guimarães AC, Sleigh AC, Ramos NB, Mott KE, Weller TH, 1987. Cardiac morbidity and mortality due to Chagas disease: prospective electrocardiographic study of a Brazilian community. Circulation 75: 1140-1145.
3. Teixeira ARL, 1987. The stercorarian trypanosomes. Soulsby EJL, ed. Immune Responses in Parasitic Infections: Immunology, Immunopathology and Immunoprophylaxis. Boca Raton: CRC, 125-145.
4. Moncayo A, 1993. Chagas disease-tropical disease research progress 1991-1992. Eleventh Program Report of the UNDP/ World Bank/WhO Special Program for Research and Training of Tropical Diseases (TDR). World Health Organization, Geneva, 67-75.
5. Urbina JA, 1997. Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplast parasites. Parasitol 114: 591-599.
6. Urbina JA, Payares G, Molina J, Sanoja C, Liendo A, Lazardi K, Piras MM, Piras R, Perez, N, Winckey P, Riley JF, 1996. Cure of short-and long-term experimental Chagas disease using D0870. Science 273: 969-971.
7. Apt W, Aguilera AA, Arribada A, Perez C, Miranda C, Sanchez G, Zulantay I, Cortés P, Rodriguez J, Juri D, 1998. Treatment of chronic Chagas disease with itraconazole and allopurinol. Am J Trop Med Hyg 59: 133-138.
8. Castro SL, 1993. The challenge of Chagas disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi. Acta Tropica 53: 83-88.
9. Parada H, Carrasco HA, Anez N, Fuenmayor C, Inglessis I, 1997. Cardiac involvement is a constant finding in acute Chagas disease: a clinical, parasitological and hislopathological study. Internatl J Cardiol 60: 49-54.
10. Andrade AL, Zicker F, Oliveira RM, 1996. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 348: 1407-1413.
11. Estani SS, Segura EL, Ruiz AM, Velasquez E, Porcel BM, Yampotis C, 1998. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas disease. Am J Trop Med Hyg 59: 526-529.
12. Coura JR, Abreu LL, Willcox HPF, Petana W, 1997. Estudo comparativo controlado com emprego de benznidazole, nifurtimox e placebo, na forma crônica da doenca de Chagas, em uma área endêmica com transmissão interrompida. I. Avaliação preliminar. Rev Soc Bras Med Trop 30: 139-144.
13. Viotti R, Vigliano C, Armenti H, Segura E, 1994. Treatment of chronic Chagas disease with benznidazole: clinical and serological evolution of patients with long term follow-up. Am Heart Journal 127: 151-162.
14. Ferreira HO, 1990. Tratamento da forma indeterminada da doença de Chagas com nifurtimox e benzonidazol. Rev Soc Bras Med Trop 23: 209-211.
15. Teixeira ARL, Cunha-Neto E, Rizzo LV, Silva R, 1990. Trypanocidal nitroarene treatment of experimental Trypanosoma cruzi infections does not prevent progression of chronic-phase heart lesions in rabbits. J Injec Dis 162: 1420.
16. Flores-Vieira CL, Antunes Barreira A, 1997. Experimental benznidazole encephalopathy: I. clinical-neurological alterations. J Neurol Sci 150: 3-11.
17. Flores-Vieira CL, Chimelli L, Franca Fernandes RM, Antunes Barreira A, 1997. Experimental benznidazole encephalopathy: II. Electroencephalographic and morphological alterations. J Neurol Sci 150: 13-25.
18. Tinoco DL, Garcia MP, Lauria-Pires L, Santana JM, Teixeira ARL, 1996. The use of four immunologic assays for diagnosis of Chagas disease in street-sweepers of the Federal District, Brazil. Rev Soc Bras Med Trop 29: 33-40.
19. Teixeira ARL, Figueiredo F, Rezende Filho J, 1995. Delayed hypersensitivity to Trypanosoma cruzi antigens. II. The use of the skin testing with the T12E antigen for diagnosis of Chagas disease. Rev Soc Bras Med Trop 28: 259-265.
20. Teixeira ARL, Figueiredo F, Rezende Fiho J, Macedo V, 1983. Chagas disease: a clinical, parasitological, immunological, and pathological study in rabbits. Am J Trop Med. Hyg 32: 258-272.
21. Kontos MC, Arrowood JA, Jesse RL, Ornato JP, Walter HP, Tatum JL, Nixon JV, 1998. Comparison between 2-dimensional echocardiogram and myocardial perfusion imaging in the emergency department in patients with possible myocardial ischemia. Am Heart Journal 136: 724-733.
22. Bestetti RB, Dalbo CMR, Freitas CO, 1994. Non-invasive predictors of mortality for patients with Chagas heart disease: a multiple step wise logistic regression study. Cardiology 84: 261-267.
23. Sturm NR, Degrave W, Morel CM, Simpson L, 1984. Sensitive detection and schizodeme classification of Trypanosoma cruzi by amplification of kinetoplast minicircle DNA sequences: use in the diagnosis of Chagas disease. Mol Biochem Parasitol 33: 205-214.
24. Avila HA, Sigman DS, Coohen LM, Millikan RC, Simpson L, 1991. Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of chronic Chagas disease. Mol Biochem Parasitol 48: 211-222.
25. Requena JM, Jimenez-Ruiz A, Soto RM, Lopez MC, Alonso C, 1992. Characterization of a highly repeated interspersed DNA sequence of Trypanosoma cruzi. Its potential use in diagnosis and strain classification. Mol Biochem Parasitol 51: 271-280.
26. Degrave W, Fragoso SP, Britto C, Heurvrrswyn GZ, Kidane AB, Cardoso U, Mueller L, Simpson L, Morel CM, 1988. Peculiar sequence organization of kinetoplast DNA minicircles from Trypanosoma cruzi. Mol Biochem Parasitol 27: 63-70.
27. Centurion-Lara A, Barret L, Van Voorhis WC, 1994. Quantitation of parasitemia by competitive polymerase chain reaction. Amplification of parasite kDNA minicircles during chronic infection with Trypanosoma cruzi. J Infec Dis 170: 1334-1339.
28. Agresti A, 1996. Introduction to Categorical Data Analysis. New York: John Wiley & Sons, 60-64.
29. Teixeira ARL, Argañaraz ER, Freitas Jr LH, Lacava ZGM, Santana JM, Luna H, 1994. Possible integration of Trypanosoma cruzi kDNA minicircles into host cell genome by infection. Mut Res 305: 197-209.
30. Teixeira ARL, Jabur E, Souto Maior IC, Solorzano E, 1983. Suppression of cell mediated immune response during administration of benznidazole. Rev Soc Bras Med Trop 16: 11-22.
31. Bocchi EA, Higuchi ML, Vieira ML, Stolf N, Bellotti G, Fiorelli A, Uip D, Jatene A, Pileggi F, 1998. Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas heart disease. J Heart Lung Transplant 17: 399-405.
32. Maguirre JH, Ramos NB, Santana OO, Almeida EC, Guimaraes AC, 1981. Comparação do eletrocardiograma convencional com o eletrocardiograma dinâmico na avaliação das arritmias na doença de Chagas. Arq Bras Cardiol 37: 82-83.
33. Kerndt PR, Waskin HA, Kirchhoff LV, Steurer F, Waterman SH, Nelson JM, Gellert GA, Shulman IA, 1991. Prevalence of antibody to Trypanosoma cruzi among blood donors in Los Angeles, California. Transfusion 31: 814-818.
34. Kirchhoff LV, 1992. Perspective on Chagas disease in Latin America and United States. Walker DH, ed. Global Medicine: Current Status and Directions for the Twenty-First Century. New York: Springer Verlag, 219-226.
35. 51Cr release from human heart cells in Chagas disease. Am J Trop Med Hyg 27: 1097-1107.
36. Cunha-Neto E, Rizzo LV, Teixeira ARL, 1989. Autoimmunity in Chagas disease: specific inhibition of reactivity of CD4+ T cells against myosin in mice chronically infected with Trypanosoma cruzi. Infect Immun 57: 2640-2644.
37. Ribeiro dos Santos R, Rossi MA, Laus JL, Santana Silva J, Savino W, Mengel J, 1992. Anti-Cd4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. J Exp Med 175: 29-39.
38. Cunha-Neto E, Duranti M, Gruber A, Zingales B, Messias I, Stolf N, Belloti G, Patarroyo ME, Pileggi F, Kalil JE, 1995. Autoimmunity in Chagas disease: biological relevance of a cardiac myosin-specific epitope cross-reactive to an immunodominant Trypanosoma cruzi antigen. Proc Natl Acad Sci USA 92: 3541-3545.
39. Higuchi ML, Ries MM, Aiello VD, Benvenutti LA, Gutierrez PS, Bellotti G, Pileggi F, 1997. Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, Chagasic myocarditis. Am J Trop Med Hyg 56: 485-489.
40. Tarleton RL, Zhang L, Downs MO, 1997. Autoimmune rejection of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue. Proc Natl Acad Sci USA 94: 3932-3937.
41. Teixeira ARL, Cordoba JC, Souto-Maior IC, Solorzano E, 1990. Chagas disease: Lymphoma growth in rabbits treated with benznidazole. Am J Trop Med Hyg 43: 146-158.
42. Teixeira ARL, Silva R, Cunha-Neto E, Santana JM, Rizzo LV, 1990. Malignant, non-Hodgkin's lymphomas in Trypanosoma cruzi-infected rabbits treated with nitroarenes. J Comp Path 103: 37-48.
43. Teixeira ARL, Calixto MA, Teixeira ML, 1994. Chagas disease: carcinogenic activity of the antitrypanosomal nitroarenes in mice. Mut Res 305: 189-196.
44. Buchner FS, Wilson AJ, White TC, Van Voorhis WC, 1998. Induction of resistance to azole drugs in Trypanosoma cruzi. Antimicrob Agents Chemother 42: 3245-3250.
45. Murta SM, Gazzinelli RT, Brener Z, Romanha AJ, 1998. Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox. Mol Biochem Parasitol 93: 203-214.
46. Murta SM, Romanha AJ, 1998. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole. Parasitol 116: 165-171.